Concepedia

2-Arylbenzoxazoles as CETP inhibitors: Raising HDL-C in cynoCETP transgenic mice

Florida Kallashi, Dooseop Kim, Jennifer E. Kowalchick, You Jung Park, Julianne A. Hunt, Amjad Ali, Cameron J. Smith, Milton L. Hammond, James V. Pivnichny, Xinchun Tong,

Bioorganic & Medicinal Chemistry Letters · 2010 · 29 citations · 6 references

DOIFull text

Open access

Concepts

References

6

Effects of Torcetrapib in Patients at High Risk for Coronary Events

Philip J. Barter, Mark J. Caulfield, Mats Eriksson et al. · New England Journal of Medicine · 2007 · 3.1K citations · Full text

, , +14

Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients

Daniel M. Bloomfield, Gary L. Carlson, Aditi Sapre et al. · American Heart Journal · 2008 · 244 citations

, , +12

2-Arylbenzoxazoles as CETP inhibitors: Substitution of the benzoxazole moiety

Cameron J. Smith, Amjad Ali, Liya Chen et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 40 citations · Full text

, , +5

2-Arylbenzoxazoles as novel cholesteryl ester transfer protein inhibitors: Optimization via array synthesis

Lalgudi S. Harikrishnan, Muthoni G. Kamau, Timothy F. Herpin et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 38 citations · Full text

, , +10

2-Arylbenzoxazoles as CETP inhibitors: Substitution and modification of the α-alkoxyamide moiety

Julianne A. Hunt, Silvia González, Florida Kallashi et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 26 citations · Full text

, , +6